🟢 HCW Biologics is trading 6.67% up in after-hours trading amid broad risk-on sentiment

HCW Biologics is trading at $2.08 with a +6.67% change in after-hours trading, appearing aligned with broad risk-on sentiment.

• No new company-specific announcement or earnings release was identified for September 17, 2026.
• The S&P 500, Nasdaq Composite, and Dow Jones gained 1.10%, 1.68%, and 0.60%, respectively.
• The latest company-specific development was the September 8 Akron Biotech distribution agreement, which was not released during this session.